Purpose of the Review: The purpose of the review was to evaluate the available literature concerning a novel minimally invasive temporary implantable nitinol device (TIND) for the treatment of benign prostatic hyperplasia (BPH), named MEDITATE (Medi-Tate®; Medi-Tate Ltd., Or Akiva, Israel). Recent Findings: A novel technique based on an innovative device was presented being temporary implantable. Clinical experiences with MEDITATE TIND have been started. Up-to-date promising outcomes are reported. Summary: TIND can be a viable minimally invasive surgical approach in the treatment of lower urinary tract symptoms correlated to benign prostate hyperplasia. Best candidates are patients who are unfit for major surgeries, patients who are refractory to standard medical treatment and patients who would like to preserve ejaculation. © 2017, Springer Science+Business Media New York.
Meditate Temporary Implantable Nitinol Device
Bertolo, Riccardo;
2017-01-01
Abstract
Purpose of the Review: The purpose of the review was to evaluate the available literature concerning a novel minimally invasive temporary implantable nitinol device (TIND) for the treatment of benign prostatic hyperplasia (BPH), named MEDITATE (Medi-Tate®; Medi-Tate Ltd., Or Akiva, Israel). Recent Findings: A novel technique based on an innovative device was presented being temporary implantable. Clinical experiences with MEDITATE TIND have been started. Up-to-date promising outcomes are reported. Summary: TIND can be a viable minimally invasive surgical approach in the treatment of lower urinary tract symptoms correlated to benign prostate hyperplasia. Best candidates are patients who are unfit for major surgeries, patients who are refractory to standard medical treatment and patients who would like to preserve ejaculation. © 2017, Springer Science+Business Media New York.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
